TECH OUTLOOK 4NOVEMBER 2023Gene Therapy--Therapeutic Viral Vectors; Manufacturing, Challenges, and InnovationTHE VALUE OF TECHNOLOGY IN PHARMACOVIGILANCEIN MY OPINIONRachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen CorpAnnette Stemhagen, Senior Vice President, Epidemiology and Risk Management, UBCLAST WORD0830HOW CMOs/CDMOs CAN ADD VALUE FOR PHARMA COMPANIESCOVER STORY12Ozgur Akbulut, Director, Global Divestments and Contract Manufacturing Lead, Takeda [NYSE:TAK]
< Page 3 | Page 5 >